News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
222,457 Results
Type
Article (18362)
Company Profile (153)
Press Release (203942)
Section
Business (61732)
Career Advice (197)
Deals (8997)
Drug Delivery (58)
Drug Development (33972)
Employer Resources (33)
FDA (6754)
Job Trends (6250)
News (112146)
Policy (11326)
Tag
2024 BioCapital Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (6)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1578)
Academic (1)
Accelerated approval (3)
Adcomms (11)
Allergies (40)
Alliances (17756)
ALS (41)
Alzheimer's disease (577)
Antibody-drug conjugate (ADC) (38)
Approvals (6807)
Artificial intelligence (126)
Autoimmune disease (8)
Automation (6)
Bankruptcy (55)
Best Places to Work (5991)
BIOSECURE Act (6)
Biosimilars (58)
Biotechnology (112)
Bladder cancer (33)
Brain cancer (12)
Breast cancer (126)
Cancer (998)
Cardiovascular disease (102)
Career advice (175)
Career pathing (6)
CAR-T (73)
Cell therapy (209)
Cervical cancer (9)
Clinical research (28240)
Collaboration (423)
Compensation (164)
Complete response letters (8)
COVID-19 (1080)
CRISPR (31)
C-suite (118)
Cystic fibrosis (57)
Data (1153)
Decentralized trials (1)
Denatured (13)
Depression (17)
Diabetes (143)
Diagnostics (2215)
Digital health (8)
Diversity (6)
Diversity, equity & inclusion (12)
Drug discovery (66)
Drug pricing (57)
Drug shortages (17)
Duchenne muscular dystrophy (50)
Earnings (18805)
Editorial (12)
Employer branding (2)
Employer resources (31)
Events (32955)
Executive appointments (327)
FDA (7358)
Featured Employer (31)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (288)
Gene editing (74)
Generative AI (14)
Gene therapy (174)
GLP-1 (384)
Government (1585)
Grass and pollen (1)
Guidances (23)
Healthcare (7644)
Huntington's disease (10)
IgA nephropathy (16)
Immunology and inflammation (43)
Indications (19)
Infectious disease (1149)
Inflammatory bowel disease (93)
Inflation Reduction Act (4)
Influenza (25)
Intellectual property (35)
Interviews (14)
IPO (4333)
IRA (21)
Job creations (719)
Job search strategy (167)
Kidney cancer (6)
Labor market (7)
Layoffs (127)
Leadership (2)
Legal (1793)
Liver cancer (29)
Lung cancer (151)
Lymphoma (88)
Machine learning (3)
Management (10)
Manufacturing (123)
MASH (35)
Medical device (2565)
Medtech (2566)
Mergers & acquisitions (4862)
Metabolic disorders (368)
Multiple sclerosis (33)
NASH (12)
Neurodegenerative disease (33)
Neuropsychiatric disorders (8)
Neuroscience (814)
NextGen: Class of 2025 (2128)
Non-profit (1695)
Northern California (1144)
Now hiring (7)
Obesity (209)
Opinion (72)
Ovarian cancer (38)
Pain (48)
Pancreatic cancer (24)
Parkinson's disease (53)
Partnered (10)
Patents (72)
Patient recruitment (40)
Peanut (23)
People (22250)
Pharmaceutical (34)
Pharmacy benefit managers (8)
Phase I (7843)
Phase II (11423)
Phase III (11058)
Pipeline (505)
Podcasts (28)
Policy (56)
Postmarket research (1436)
Preclinical (3080)
Press Release (15)
Prostate cancer (49)
Psychedelics (9)
Radiopharmaceuticals (142)
Rare diseases (213)
Real estate (1537)
Recruiting (9)
Regulatory (8972)
Reports (12)
Research institute (1346)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (3)
RSV (17)
Schizophrenia (34)
Series A (61)
Series B (44)
Service/supplier (1)
Sickle cell disease (38)
Southern California (875)
Special edition (6)
Spinal muscular atrophy (84)
Sponsored (10)
Startups (1356)
Stomach cancer (6)
Supply chain (32)
The Weekly (14)
United States (9282)
Vaccines (282)
Venture capitalists (16)
Webinars (3)
Weight loss (127)
Women's health (13)
Worklife (1)
Date
Today (58)
Last 7 days (321)
Last 30 days (1219)
Last 365 days (15147)
2025 (3742)
2024 (15468)
2023 (16757)
2022 (20916)
2021 (21716)
2020 (19862)
2019 (17099)
2018 (12827)
2017 (12034)
2016 (11196)
2015 (12067)
2014 (8450)
2013 (6942)
2012 (7035)
2011 (6999)
2010 (5670)
Location
Africa (236)
Alabama (24)
Alaska (1)
Arizona (45)
Arkansas (3)
Asia (15004)
Australia (2084)
California (2419)
Canada (610)
China (249)
Colorado (81)
Connecticut (133)
Delaware (91)
Europe (33485)
Florida (344)
Georgia (64)
Idaho (15)
Illinois (219)
India (15)
Indiana (169)
Iowa (3)
Japan (109)
Kansas (34)
Kentucky (7)
Louisiana (3)
Maine (26)
Maryland (273)
Massachusetts (2085)
Michigan (32)
Minnesota (68)
Mississippi (1)
Missouri (37)
Montana (7)
Nebraska (4)
Nevada (10)
New Hampshire (10)
New Jersey (900)
New Mexico (10)
New York (713)
North Carolina (424)
North Dakota (5)
Northern California (1144)
Ohio (74)
Oklahoma (4)
Oregon (17)
Pennsylvania (506)
Puerto Rico (1)
Rhode Island (7)
South America (296)
South Carolina (3)
Southern California (875)
Tennessee (24)
Texas (254)
Utah (85)
Virginia (58)
Washington D.C. (32)
Washington State (253)
Wisconsin (23)
222,457 Results for "kainos medicines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine
Emmaus Life Sciences, Inc. today announced the signing of an agreement with Kainos Medicine, Inc.
October 12, 2021
·
3 min read
Business
MDimune pens FAF1 mRNA cancer drug deal with Kainos Medicine
MDimune Inc. and Kainos Medicine, Inc., has inked a collaboration pact and possible licensing deal with MDimune Inc. for disruptive cancer therapy development based on cell-derived vesicles (CDVs) like extracellular vesicles (EVs) loaded with Fas-associated Factor 1 (FAF1) expressing mRNA or protein.
October 29, 2021
·
2 min read
Partnered
All About Speed: Lilly Drives Innovation With New Facility to Help Bring Medicines to Market
Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high demand for its medicines. Its recently announced Lilly Medicine Foundry—which will support research and development efforts—is just the latest example of the ability to research new ways of producing medicines, while also scaling up manufacturing of medicines for clinical trials.
January 6, 2025
·
5 min read
·
BioSpace Insights
Press Releases
Solidsoft Reply Successfully Integrates the Hellenic Medicines Verification System into the European Medicines Verification Platform
March 18, 2025
·
3 min read
Cell therapy
Galapagos to Spin Out Innovative Medicines, Lay Off 40%
By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell therapy company, the latter of which will inherit the Galapagos name.
January 8, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting
March 28, 2025
·
20 min read
Press Releases
Revolution Medicines to Participate in April 2025 Investor Conferences
April 1, 2025
·
1 min read
Business
Emmaus Life Sciences Announces Collaboration with Kainos Medicine for Preclinical Development of IRAK4 Inhibitor as Potential Anti-Cancer Drug
Emmaus Life Sciences, Inc. (OTC: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today that it has entered into an agreement with Kainos Medicine, Inc. (“Kainos”) to lead the preclinical development of Kainos’ patented IRAK4 inhibitor (KM10544) as an anti-cancer drug
March 2, 2021
·
4 min read
Venture Capitalists
Novo-Backed Oral Medicine Biotech Adds Lilly to Investors in $93M Series A
Orbis emerged from stealth in February 2024 with $28.1 million in seed funding. The Danish biotech, which aims to flip biologics into oral medicines, has now raised another $93 million.
January 6, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Editas Medicine Announces Chief Financial Officer Transition
March 21, 2025
·
3 min read
1 of 22,246
Next